Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

Author:

Oaknin Ana1,Tinker Anna V.2,Gilbert Lucy3,Samouëlian Vanessa4,Mathews Cara5,Brown Jubilee6,Barretina-Ginesta Maria-Pilar78,Moreno Victor9,Gravina Adriano10,Abdeddaim Cyril11,Banerjee Susana12,Guo Wei13,Danaee Hadi14,Im Ellie15,Sabatier Renaud16

Affiliation:

1. Medical Oncology Department, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

2. Division of Medical Oncology, BC Cancer–Vancouver, Vancouver, British Columbia, Canada

3. Division of Gynecologic Oncology, McGill University Health Centre, Montreal, Quebec, Canada

4. Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada

5. Women and Infants’ Program in Women’s Oncology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island

6. Levine Cancer Institute, Division of Gynecologic Oncology, Atrium Health, Charlotte, North Carolina

7. Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain

8. Girona Biomedical Research Institute, Department of Medical Sciences, Medical School University of Girona, Girona, Spain

9. START Madrid-Fundación Jiménez Díaz, Hospital Fundación Jiménez Díaz, Madrid, Spain

10. Struttura Complessa Sperimentazioni Cliniche, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Pascale, Naples, Italy

11. Department of Gynecological Oncology, Centre de Lutte Contre le Cancer–Centre Oscar Lambret, Lille, France

12. Gynaecology Unit, The Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, London, United Kingdom

13. Oncology Development Bioststats Unit, GlaxoSmithKline, Waltham, Massachusetts

14. Experimental Medicine Unit, GlaxoSmithKline, Waltham, Massachusetts

15. Oncology Clinical Development—Immuno-Oncology Clinical Unit, GlaxoSmithKline, Waltham, Massachusetts

16. Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille–Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Department of Medical Oncology, Aix-Marseille University, Inserm, Centre National de la Recherche Scientifique, Marseille, France

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3